These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 22054145)

  • 21. Bariatric surgery and the gut-brain communication--the state of the art three years later.
    Diniz Mde F; Azeredo Passos VM; Diniz MT
    Nutrition; 2010 Oct; 26(10):925-31. PubMed ID: 20392599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathophysiology of obesity: why surgery remains the most effective treatment.
    Waseem T; Mogensen KM; Lautz DB; Robinson MK
    Obes Surg; 2007 Oct; 17(10):1389-98. PubMed ID: 18000735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms facilitating weight loss and resolution of type 2 diabetes following bariatric surgery.
    Karra E; Yousseif A; Batterham RL
    Trends Endocrinol Metab; 2010 Jun; 21(6):337-44. PubMed ID: 20133150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss.
    Gumbs AA; Modlin IM; Ballantyne GH
    Obes Surg; 2005 Apr; 15(4):462-73. PubMed ID: 15946423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Metabolic effects of bariatric surgery].
    Winkler G
    Orv Hetil; 2013 Jan; 154(1):3-9. PubMed ID: 23274228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beneficial Metabolic Effects of Duodenal Jejunal Bypass Liner for the Treatment of Adipose Patients with Type 2 Diabetes Mellitus: Analysis of Responders and Non-Responders.
    Stratmann B; Krepak Y; Schiffer E; Jarick I; Hauber M; Lee-Barkey YH; Fischer M; Tschoepe D
    Horm Metab Res; 2016 Sep; 48(10):630-637. PubMed ID: 27589345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type-II diabetes mellitus.
    Clements RH; Gonzalez QH; Long CI; Wittert G; Laws HL
    Am Surg; 2004 Jan; 70(1):1-4; discussion 4-5. PubMed ID: 14964537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endocrine and metabolic response to gastric bypass.
    Saliba J; Wattacheril J; Abumrad NN
    Curr Opin Clin Nutr Metab Care; 2009 Sep; 12(5):515-21. PubMed ID: 19535977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms underlying weight loss after bariatric surgery.
    Miras AD; le Roux CW
    Nat Rev Gastroenterol Hepatol; 2013 Oct; 10(10):575-84. PubMed ID: 23835488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gastrointestinal hormones and weight loss response after Roux-en-Y gastric bypass.
    de Hollanda A; Jiménez A; Corcelles R; Lacy AM; Patrascioiu I; Vidal J
    Surg Obes Relat Dis; 2014; 10(5):814-9. PubMed ID: 24969090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: understanding weight loss and improvements in type 2 diabetes after bariatric surgery.
    Scott WR; Batterham RL
    Am J Physiol Regul Integr Comp Physiol; 2011 Jul; 301(1):R15-27. PubMed ID: 21474429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GIP and bariatric surgery.
    Rao RS; Kini S
    Obes Surg; 2011 Feb; 21(2):244-52. PubMed ID: 21082290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of bariatric surgery on gut hormones that alter appetite.
    Pournaras DJ; Le Roux CW
    Diabetes Metab; 2009 Dec; 35(6 Pt 2):508-12. PubMed ID: 20152735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetes remission after bariatric surgery: is it just the incretins?
    Laferrère B
    Int J Obes (Lond); 2011 Sep; 35 Suppl 3(0 3):S22-5. PubMed ID: 21912382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgical treatments for obesity.
    Vetter ML; Dumon KR; Williams NN
    Psychiatr Clin North Am; 2011 Dec; 34(4):881-93. PubMed ID: 22098811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The enteroinsular axis and the recovery from type 2 diabetes after bariatric surgery.
    Patriti A; Facchiano E; Sanna A; Gullà N; Donini A
    Obes Surg; 2004; 14(6):840-8. PubMed ID: 15318993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Roux-en-Y gastric bypass on the distribution and hormone expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetes.
    Rhee NA; Wahlgren CD; Pedersen J; Mortensen B; Langholz E; Wandall EP; Friis SU; Vilmann P; Paulsen SJ; Kristiansen VB; Jelsing J; Dalbøge LS; Poulsen SS; Holst JJ; Vilsbøll T; Knop FK
    Diabetologia; 2015 Oct; 58(10):2254-8. PubMed ID: 26186884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The post-prandial pattern of gut hormones is related to magnitude of weight-loss following gastric bypass surgery: a case-control study.
    Gerner T; Johansen OE; Olufsen M; Torjesen PA; Tveit A
    Scand J Clin Lab Invest; 2014 Apr; 74(3):213-8. PubMed ID: 24472033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of weight loss after bariatric surgery for morbid obesity on vascular endothelial growth factor-A, adipocytokines, and insulin.
    García de la Torre N; Rubio MA; Bordiú E; Cabrerizo L; Aparicio E; Hernández C; Sánchez-Pernaute A; Díez-Valladares L; Torres AJ; Puente M; Charro AL
    J Clin Endocrinol Metab; 2008 Nov; 93(11):4276-81. PubMed ID: 18713823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ASMBS Position Statement on medium- and long-term durability of weight loss and diabetic outcomes after conventional stapled bariatric procedures.
    Azagury D; Papasavas P; Hamdallah I; Gagner M; Kim J
    Surg Obes Relat Dis; 2018 Oct; 14(10):1425-1441. PubMed ID: 30242000
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.